Review article · 2023
Target protein degradation by protacs: A budding cancer treatment strategy
Pharmacology & Therapeutics, 250, 108525 · Published 9 September 2023 · DOI 10.1016/j.pharmthera.2023.108525
In brief
“Target protein degradation by protacs: A budding cancer treatment strategy” is a 2023 review article by Diksha Choudhary and 8 co-authors, published in Pharmacology & Therapeutics. OpenAlex counts 33 citations as of 21 November 2026, which puts it in the top 5% of works published in 2023 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 33
- Most cited in
- 2026 (14)
- Field-weighted impact
- 0.75
- References
- 183
- Authors
- 9
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Choudhary, D., Kaur, A., Singh, P., Chaudhary, G., Kaur, R., Bayan, M. F., Chandrasekaran, B., Marji, S. M., & Ayman, R. (2023). Target protein degradation by protacs: A budding cancer treatment strategy. Pharmacology & Therapeutics, 250, 108525. https://doi.org/10.1016/j.pharmthera.2023.108525
MLA 9
Choudhary, Diksha, et al. “Target protein degradation by protacs: A budding cancer treatment strategy.” Pharmacology & Therapeutics, vol. 250, 2023, p. 108525. https://doi.org/10.1016/j.pharmthera.2023.108525.
Chicago
Choudhary, Diksha, Amritpal Kaur, Pargat Singh, Gaurav Chaudhary, Rajwinder Kaur, Mohammad F. Bayan, Balakumar Chandrasekaran, Saeed M. Marji, and Reema Ayman. 2023. “Target protein degradation by protacs: A budding cancer treatment strategy.” Pharmacology & Therapeutics 250: 108525. https://doi.org/10.1016/j.pharmthera.2023.108525.
Harvard
Choudhary, D. et al. (2023) ‘Target protein degradation by protacs: A budding cancer treatment strategy’, Pharmacology & Therapeutics, 250, p. 108525. doi:10.1016/j.pharmthera.2023.108525.
IEEE
D. Choudhary et al., “Target protein degradation by protacs: A budding cancer treatment strategy,” Pharmacology & Therapeutics, vol. 250, p. 108525, 2023, doi: 10.1016/j.pharmthera.2023.108525.
BibTeX
@article{choudhary2023target,
title = {{Target protein degradation by protacs: A budding cancer treatment strategy}},
author = {Choudhary, Diksha and Kaur, Amritpal and Singh, Pargat and Chaudhary, Gaurav and Kaur, Rajwinder and Bayan, Mohammad F. and Chandrasekaran, Balakumar and Marji, Saeed M. and Ayman, Reema},
journal = {Pharmacology \& Therapeutics},
year = {2023},
volume = {250},
pages = {108525},
doi = {10.1016/j.pharmthera.2023.108525},
url = {https://doi.org/10.1016/j.pharmthera.2023.108525}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2023 | 3 | |
| 2024 | 6 | |
| 2025 | 10 | |
| 2026 | 14 |
Its field-weighted citation impact is 0.75: it has been cited 0.75 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- PROTACs
- targeted protein degradation
- cancer therapy
- mechanism of action
- undruggable targets
- pharmacokinetics
Work with this paper
Most-cited papers in Biochemistry, Genetics and Molecular Biology
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTOliver H. Lowry, NiraJ. Rosebrough, A. Lewis Farr and 1 more · Journal of Biological Chemistry · 1951 · 316,470 citations
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingM Bradford · Analytical Biochemistry · 1976 · 256,780 citations
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodKenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 184,418 citations
- Molecular Cloning: A Laboratory ManualJoseph Sambrook, Elisabeth Fritsch, Tom Maniatis · UCLA - Biblioteca de Ciencias de la Salud · 1989 · 133,493 citations
- Basic Local Alignment Search ToolStephen F. Altschul, Warren R. Gish, Webb Miller and 2 more · Journal of Molecular Biology · 1990 · 100,529 citations
All highly cited Biochemistry, Genetics and Molecular Biology papers
Questions about this paper
How do I cite this paper in APA style?
Choudhary, D., Kaur, A., Singh, P., Chaudhary, G., Kaur, R., Bayan, M. F., Chandrasekaran, B., Marji, S. M., & Ayman, R. (2023). Target protein degradation by protacs: A budding cancer treatment strategy. Pharmacology & Therapeutics, 250, 108525. https://doi.org/10.1016/j.pharmthera.2023.108525
How many times has this paper been cited?
33 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Diksha Choudhary, Amritpal Kaur, Pargat Singh, Gaurav Chaudhary, Rajwinder Kaur, Mohammad F. Bayan, Balakumar Chandrasekaran, Saeed M. Marji, Reema Ayman.
What is the DOI of this paper?
10.1016/j.pharmthera.2023.108525, permanently at https://doi.org/10.1016/j.pharmthera.2023.108525. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.